NCT00705081 arm group 4066ba69557f833fe9dea296d1c697c4 [clinicaltrials_resource:NCT00705081/arm-group/4066ba69557f833fe9dea296d1c697c4]
ezetimibe [clinicaltrials_resource:4df15d5a31eb4c3b35063558231ec45c]statin [clinicaltrials_resource:73777d84c3c1ae76aafe72b0002dce36]Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED) [clinicaltrials:NCT00705081]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00705081 arm group 4066ba69557f833fe9dea296d1c697c4 [clinicaltrials_resource:NCT00705081/arm-group/4066ba69557f833fe9dea296d1c697c4]
Bio2RDF identifier
NCT00705081/arm-group/4066ba69557f833fe9dea296d1c697c4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 66ba69557f833fe9dea296d1c697c4
description [clinicaltrials_vocabulary:description]
subjects with hypercholesterol ...... timibe 10 mg as add-on therapy
identifier
clinicaltrials_resource:NCT00705081/arm-group/4066ba69557f833fe9dea296d1c697c4
title
NCT00705081 arm group 4066ba69557f833fe9dea296d1c697c4
@en
type
label
NCT00705081 arm group 4066ba69 ...... 6ba69557f833fe9dea296d1c697c4]
@en